NCT04974216
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04974216
Title Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications
Therapies
Age Groups: senior
Covered Countries FRA | BEL

Facility Status City State Zip Country Details
Clinique Universitaire Saint LUC Brussels Belgium Details
Grand Hopital De Charleroi Charleroi 6000 Belgium Details
CHU Helora La Louvière 7100 Belgium Details
CHU de Liège Liège Belgium Details
CHRU Mont Godinne Yvoir Belgium Details
Centre Hospitalier D Avignon Avignon France Details
Centre Hospitalier De La Cote Basque Bayonne France Details
Besancon University Hospital Center Besançon 25030 France Details
CHU de Bordeaux - Hôpital Haut Lévêque Bordeaux France Details
Institut Bergonié - Bordeaux Bordeaux France Details
Centre Hospitalier Sud Francilien Corbeil-Essonnes France Details
Centre Hospitalier Departemental Vendee La Roche-sur-Yon France Details
CH Saint Vincent de Paul Lille France Details
CHRU de LILLE - Claude Huriez Lille France Details
Chu de Limoges - Hopital Dupuytren Limoges France Details
CHU de Nantes - Hôtel Dieu Nantes France Details
APHP - Hôpital Saint Louis Paris France Details
Centre Henri Becquerel Rouen France Details
Institut de Cancérologie de la Loire Lucien Neuwirth Saint-Priest-en-Jarez 42270 France Details
CHU Brabois Vandœuvre-lès-Nancy France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field